{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T16:09:25Z","timestamp":1707581365302},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2010.03.014","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T05:17:16Z","timestamp":1284614236000},"page":"11-17","source":"Crossref","is-referenced-by-count":3,"title":["Prestroke Anticoagulation and Paroxysmal Type Are Correlated With Favorable Outcome in Ischemic Stroke Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"21","author":[{"given":"Haruhiko","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Miyaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ahj.2004.09.053","article-title":"Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation","volume":"149","author":"Kerr","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke Prevention in Atrial Fibrillation Investigators. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib4","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jacc.2007.07.076","article-title":"Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: An ACTIVE-W substudy","volume":"50","author":"Hohnloser","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000095288","article-title":"Cerebrovascular incidents differ in patients with permanent and paroxysmal atrial fibrillation","volume":"22","author":"Staszewski","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0404.2008.01100.x","article-title":"Strokes in paroxysmal atrial fibrillation have more favorable outcome than in permanent atrial fibrillation","volume":"119","author":"Staszewski","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Analysis of pooled data from five randomized controlled trials","volume":"154","author":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(06)70536-1","article-title":"Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: An observational study","volume":"5","author":"O'Donnell","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib10","unstructured":"Japanese Guidelines for the Management of Stroke, 2009. Tokyo: Kyouwa Kikaku, 2009."},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5551\/jat.E537","article-title":"Diagnostic criteria for dyslipidemia: Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese","volume":"14","author":"Teramoto","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-8227(01)00365-5","article-title":"Report of the Ccommittee on the Classification and Diagnostic Criteria of Diabetes Mellitus","volume":"55","author":"Kuzuya","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib13","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000016023","article-title":"Cardioembolic vs noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the Stroke Prevention in Atrial Fibrillation studies","volume":"10","author":"Hart","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1253\/circj.68.568","article-title":"Progressive nature of paroxysmal atrial fibrillation: Observations from a 14-year follow-up study","volume":"68","author":"Kato","year":"2004","journal-title":"Circ J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-II clinical trials","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib17","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/euhj.2000.2531","article-title":"Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation: Effects of cardioversion and return of left atrial function","volume":"22","author":"Li-Saw-Hee","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1378\/chest.126.6.1938","article-title":"Warfarin anticoagulation and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis","volume":"126","author":"Reynolds","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2010.03.014_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2169\/internalmedicine.40.1183","article-title":"Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation","volume":"40","author":"Yasaka","year":"2001","journal-title":"Intern Med"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305710000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305710000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T22:20:03Z","timestamp":1544221203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305710000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1052305710000984"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2010.03.014","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}